You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Evolution of the Management of Resectable Pancreatic Cancer
Contributor:
Tsai, Susan;
Erickson, Beth A.;
Dua, Kulwinder;
Ritch, Paul S.;
Tolat, Parag;
Evans, Douglas B.
imprint:
American Society of Clinical Oncology (ASCO), 2016
Published in:Journal of Oncology Practice
Language:
English
DOI:
10.1200/jop.2016.015818
ISSN:
1554-7477;
1935-469X
Origination:
Footnote:
Description:
<jats:p> In pancreatic cancer, as with many other solid tumors, a commonly held surgical adage—a chance to cut is a chance to cure—has been promulgated throughout the years. Following such reasoning, surgical extirpation of a localized tumor would prevent tumor dissemination and metastatic tumor progression. However, decades of surgical experience have demonstrated that surgical resection alone provides a limited median survival benefit. Despite the optimization of surgical technique and perioperative management over the past three decades, little progress has been made to improve the limited survival of patients with localized pancreatic cancer who receive surgery. In this article, we discuss the rationale for a novel management strategy for patients with resectable pancreatic cancer, which may improve patient selection and the delivery of multimodality therapy. </jats:p>